Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
5811 - 5820 of 8818 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • 2019
  • 2019
  • 2019
  • 2020
  • Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergy
    2019
    Summary Details
    RESTRICTED
    Title: Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergy
    Author(s): Baruch D. Jakubovic, Amanda Jagdis, Martina Trinkaus, Anthony E. Lang, Anna Chang, Tara Rastin, Mariana Castells, Stephen Betschel
    Journal Name: The Journal of Allergy and Clinical Immunology: In Practice
    Publisher: Elsevier BV
    Vol: 8
    Issue #: 2
    Start Page: 780
    End Page: 782
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jaip.2019.07.040
    Citation Count: 1
  • Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease
    2020
    Summary Details
    OPEN
    Title: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease
    Author(s): Danielle S. Abraham, Thanh Phuong Pham Nguyen, Sean Hennessy, Shelly L. Gray, Dawei Xie, Daniel Weintraub, Allison W. Willis
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Vol: 29
    Issue #: 1
    Start Page: 35
    End Page: 47
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7671949
    Citation Count: 5
  • Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
    2019
    Summary Details
    RESTRICTED
    Title: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
    Author(s): C. Warren Olanow, Stewart A. Factor, Alberto J. Espay, Robert A. Hauser, Holly A. Shill, Stuart Isaacson, Rajesh Pahwa, Mika Leinonen, Parul Bhargava, Ken Sciarappa, Bradford Navia, David Blum, xx xx
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 2
    Start Page: 135
    End Page: 144
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5
    Citation Count: 112
  • Wearable-based mobility monitoring: the long road ahead
    2020
    Summary Details
    RESTRICTED
    Title: Wearable-based mobility monitoring: the long road ahead
    Author(s): Alfonso Fasano, Martina Mancini
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 5
    Start Page: 378
    End Page: 379
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30033-8
    Citation Count: 28
  • β-adrenoreceptors and the risk of Parkinson's disease
    2020
    Summary Details
    RESTRICTED
    Title: β-adrenoreceptors and the risk of Parkinson's disease
    Author(s): Franziska Hopfner, Günter U Höglinger, Gregor Kuhlenbäumer, Anton Pottegård, Mette Wod, Kaare Christensen, Caroline M Tanner, Günther Deuschl, Franziska Hopfner, Günter U Höglinger, Gregor Kuhlenbäumer, Mette Wod, Kaare Christensen, Caroline M Tanner, Günther Deuschl
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 3
    Start Page: 247
    End Page: 254
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4
    Citation Count: 73
  • Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study
    2020
    Summary Details
    RESTRICTED
    Title: Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study
    Author(s): Jerrold L. Vitek, Roshini Jain, Lilly Chen, Alexander I. Tröster, Lauren E. Schrock, P.A. House, Monique Giroux, Adam O. Hebb, Sierra Farris, Donald Whiting, Timothy Leichliter, Jill L. Ostrem, Marta San Luciano, Nicholas B. Galifianakis, Leo Verhagen Metman, Sepehr Sani, Jessica Karl, Mustafa Siddiqui, Stephen B. Tatter, Ihtsham Haq, André G. Machado, Michal Gostkowski, Michele Tagliati, Adam N. Mamelak, Michael S. Okun, Kelly D. Foote, Guillermo Moguel‐Cobos, Francisco A. Ponce, Rajesh Pahwa, Jules M. Nazzaro, Cathrin M. Buetefisch, Robert E. Gross, Corneliu Luca, Jonathan Jagid, Gonzalo J. Revuelta, István Takács, Michael Pourfar, Alon Y. Mogilner, Andrew P. Duker, George Mandybur, Joshua M. Rosenow, Scott E. Cooper, Michael C. Park, Suketu M. Khandhar, Mark Sedrak, Fenna T. Phibbs, Julie G. Pilitsis, Ryan J. Uitti, Philip A. Starr
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 6
    Start Page: 491
    End Page: 501
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30108-3
    Citation Count: 129
  • Multiple sclerosis in 2019: predicting progression
    2019
    Summary Details
    RESTRICTED
    Title: Multiple sclerosis in 2019: predicting progression
    Author(s): Alexis Lizarraga, Bianca Weinstock‐Guttman
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 1
    Start Page: 12
    End Page: 14
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7
    Citation Count: 1
  • Movement disorders in 2019: from antibodies to lifestyle interventions
    2019
    Summary Details
    RESTRICTED
    Title: Movement disorders in 2019: from antibodies to lifestyle interventions
    Author(s): Claudia Trenkwalder, Brit Mollenhauer
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 1
    Start Page: 10
    End Page: 12
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7
    Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133486
    Citation Count: 1
  • A cornerstone initiative for progress in Parkinson's disease
    2019
    Summary Details
    OPEN
    Title: A cornerstone initiative for progress in Parkinson's disease
    Author(s): The Lancet Neurology
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 1
    Start Page: 1
    End Page: 1
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6
    Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdf
    Citation Count: 1
  • Patient-centred management of Parkinson's disease
    2020
    Summary Details
    OPEN
    Title: Patient-centred management of Parkinson's disease
    Author(s): David Grimes, Angelo Antonini, Joaquim J. Ferreira, Alvaro Sánchez Ferro, Timothy Lynch, Oliver Rascol, Evžen Ru̇žička, Carsten Eggers, Tiago A Mestre, David Grimes, Angelo Antonini, Joaquim J. Ferreira, Alvaro Sánchez Ferro, Timothy Lynch, Oliver Rascol, Evžen Ru̇žička, Carsten Eggers, Tiago A Mestre
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 11
    Start Page: 887
    End Page: 888
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8
    Best OA location URL: http://www.thelancet.com/article/S1474442220303598/pdf
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.